We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Kidneys Could Be Damaged By Angioplasty Procedures

By HospiMedica staff writers
Posted on 17 Jul 2007
A new study has found that angioplasty procedures for clearing blocked kidney arteries can also release thousands of tiny particles into the bloodstream that could impair kidney function.

Researchers of the Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA) examined 28 angioplasty cases, using a protection device to temporarily block the vessel at the site of the angioplasty and stenting. More...
After the procedure, and while the protection system was still in place, the researchers took a small sample of blood trapped by the protection device. The artery was then aspirated and flushed out to remove any remaining particles. Laboratory analyses found a mean of 2,000 particles captured per blood sample - many of them large enough to block the small vessels in the kidney. The study was published in the July 2007 issue of the Journal for Vascular Surgery.

The more particles collected from a patient, the worse their kidney function, said lead author Matthew Edwards, M.D., M.S., an assistant professor of surgery. Patients with higher levels of particles in their blood were more likely to have decreased kidney function after the procedure. Poor kidney function after kidney artery stenting has been previously demonstrated by our group to be associated with increased risk of heart attack, stroke, or death in the future.

The researchers theorize that some blockages are more prone to releasing particles than others, and that just putting the protection device in place releases particles that reach the kidneys. Further research is needed to examine this and other issues, including how well the protection device works and how to predict which plaques are more prone to release emboli.


Related Links:
Wake Forest University Baptist Medical Center

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.